{
    "clinical_study": {
        "@rank": "156430", 
        "acronym": "DiabCare Asia", 
        "arm_group": {
            "arm_group_label": "Subjects with diabetes mellitus (type 2)"
        }, 
        "brief_summary": {
            "textblock": "This study is conducted in Asia. The aim of this non-interventional study is to evaluate the\n      current status of diabetes management, control, and complications in diabetic subjects in\n      Sri Lanka."
        }, 
        "brief_title": "A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Sri Lanka", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diabetes", 
            "Diabetes Mellitus, Type 2"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  People with type 2 diabetes mellitus (DM) who are being treated, with any of the\n             non-pharmacological or pharmacological options, at a particular centre for at least 1\n             year and who have visited the centre within the last 3-6 months\n\n          -  Patients willing to sign informed consent form\n\n        Exclusion Criteria:\n\n          -  Previous participation in this study\n\n          -  Unable to comply with protocol requirements\n\n          -  Confirmed or suspected pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "People having been treated for at least a year are eligible for the study. The selection\n        of the patients will be done randomly by the individual physician involved in the study."
            }
        }, 
        "enrollment": {
            "#text": "669", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01957592", 
            "org_study_id": "INS-4068", 
            "secondary_id": "U1111-1138-8495"
        }, 
        "intervention": {
            "arm_group_label": "Subjects with diabetes mellitus (type 2)", 
            "description": "Patients will fill out a questionnaire by interview.", 
            "intervention_name": "No treatment given", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "October 25, 2013", 
        "link": {
            "description": "Clinical Trials at Novo Nordisk", 
            "url": "http://novonordisk-trials.com"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Bangalore", 
                    "country": "Sri Lanka", 
                    "zip": "560001"
                }
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Sri Lanka"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Sri Lanka", 
        "overall_contact": {
            "email": "clinicaltrials@novonordisk.com", 
            "last_name": "Novo Nordisk"
        }, 
        "overall_official": {
            "affiliation": "Novo Nordisk Ltd.", 
            "last_name": "Prasanna Kumar", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Sri Lanka: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Proportion of patients having HbA1c ((Glycosylated Haemoglobin) as measured during survey) less than 7%", 
            "safety_issue": "No", 
            "time_frame": "Evaluated at the first visit (only one study visit)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01957592"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Mean Fasting Plasma Glucose (FPG) of patients", 
                "safety_issue": "No", 
                "time_frame": "Evaluated at the first visit (only one study visit)"
            }, 
            {
                "measure": "Mean Postprandial Plasma Glucose (PPG) of patients", 
                "safety_issue": "No", 
                "time_frame": "Evaluated at the first visit (only one study visit)"
            }, 
            {
                "measure": "Mean HbA1c of  patients", 
                "safety_issue": "No", 
                "time_frame": "Evaluated at the first visit (only one study visit)"
            }, 
            {
                "measure": "Proportion of patients having dyslipidemia", 
                "safety_issue": "No", 
                "time_frame": "Evaluated at the first visit (only one study visit)"
            }, 
            {
                "measure": "Proportion of patients having hypertension", 
                "safety_issue": "No", 
                "time_frame": "Evaluated at the first visit (only one study visit)"
            }, 
            {
                "measure": "Proportion of patients having cardiovascular complications", 
                "safety_issue": "No", 
                "time_frame": "Evaluated at the first visit (only one study visit)"
            }, 
            {
                "measure": "Proportion of  patients having peripheral vascular disease", 
                "safety_issue": "No", 
                "time_frame": "Evaluated at the first visit (only one study visit)"
            }, 
            {
                "measure": "Proportion of  patients having diabetic nephropathy", 
                "safety_issue": "No", 
                "time_frame": "Evaluated at the first visit (only one study visit)"
            }, 
            {
                "measure": "Proportion of  patients having diabetic eye complications", 
                "safety_issue": "No", 
                "time_frame": "Evaluated at the first visit (only one study visit)"
            }
        ], 
        "source": "Novo Nordisk A/S", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novo Nordisk A/S", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2014", 
        "study_design": "Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}